Eprovafen

This classification denotes a lipooxygenase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4C9310B127. European Medicines Agency schedules Eprovafen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06587MIG. Eprovafen generally arises in the molecular formula C18H22O2S. The term EPROVAFEN is an International Non-Proprietary Name or INN. EPROVAFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule eprovafen under HS 29349990 and SITC 51579. As of Q4 2014, EPROVAFEN remains the US FDA Preferred Term for this commodity. Eprovafen bears US NLM identifiers UMLS ID C1880543 and NCI Concept Code C65521. SMILES: s1c(CCCCC(=O)O)ccc1CCCc1ccccc1.